Cite
HARVARD Citation
Spalinger, M. et al. (2021). The JAK Inhibitor Tofacitinib Rescues Intestinal Barrier Defects Caused by Disrupted Epithelial-macrophage Interactions. Journal of Crohn's and colitis. pp. 471-484. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Spalinger, M. et al. (2021). The JAK Inhibitor Tofacitinib Rescues Intestinal Barrier Defects Caused by Disrupted Epithelial-macrophage Interactions. Journal of Crohn's and colitis. pp. 471-484. [Online].